iGlarLixi Safe and Effective in Inadequately Controlled T2D iGlarLixi Safe and Effective in Inadequately Controlled T2D
A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 3, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Launching an Obesity Medicine Practice? Key Considerations Launching an Obesity Medicine Practice? Key Considerations
As the treatment of obesity in the 21st century takes a monumental turn, the need for quality care is more pressing than ever: Tips for starting a new obesity-focused practice.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 3, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Small Bowel Microbiome Profiles Differ in Overweight/Obesity Small Bowel Microbiome Profiles Differ in Overweight/Obesity
Researchers have identified significant and specific variations in the microbial universe of the small intestine in overweight or obese adults compared with normal-weight peers.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 3, 2024 Category: Endocrinology Tags: Gastroenterology Clinical Summary Source Type: news
' Fighting for Approval': Barriers to Needed Medications'Fighting for Approval': Barriers to Needed Medications
Therapies such as growth hormones and puberty blockers often face shortages, leaving pediatric endocrinologists fighting to get medications for their patients.Medscape Diabetes & Endocrinology (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 2, 2024 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Commentary Source Type: news
SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease
THURSDAY, May 2, 2024 -- Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially lower risk for dialysis and cardiovascular disease in patients with type 2 diabetes (T2D) and stage 5 chronic kidney disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2024 Category: Pharmaceuticals Source Type: news
Can Unsaturated Fat Boost Muscle in People With Overweight? Can Unsaturated Fat Boost Muscle in People With Overweight?
High doses of PUFAs didn ' t differentially affect lean tissue accumulation in middle-aged individuals with overweight, as in the elderly and young lean populations.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
How We Chose the TIME100 Most Influential People in Health of 2024
In 2018, we worked with Bill Gates on a special issue of TIME dedicated to the power of optimism. Gates’ view, shared by many of the issue’s contributors, was that people are wired to focus on when things go wrong and when they don’t work. Sometimes this attention distracts us from the moments when progress is being made. Journalists fall prey to this phenomenon as much as anyone else.
[time-brightcove not-tgx=”true”]
As we put together this issue, I was reminded of the conversations with Gates that led to that project. With guidance from Dr. David Agus and Arianna Huffington, our team of ...
Source: TIME: Health - May 2, 2024 Category: Consumer Health News Authors: Sam Jacobs Tags: Uncategorized Magazine sponsorshipblock time100health2024 Source Type: news
Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst
Newly powerful weight-loss drugs became the biggest story in health in the past year—and Dr. Jens Juul Holst, Dr. Joel Habener, Svetlana Mojsov, and Dr. Daniel Drucker played pivotal roles in making those medications possible. The scientists conducted the early work, beginning in the 1970s, on glucagon-like peptides, or GLPs, that first transformed the treatment of diabetes and now that of obesity.
[time-brightcove not-tgx=”true”]
As with many groundbreaking medical developments, it was a group effort. Holst, at the University of Copenhagen (where he’s now professor of endocrinology and me...
Source: TIME: Health - May 2, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Accolades franchise Magazine Special Project sponsorshipblock time100health2024 Source Type: news
David Baker
Proteins, each with their own unique three-dimensional architecture, are the body’s molecular tools, adapted to perform the specific tasks necessary for maintaining life. For decades, researchers have modified proteins to augment or alter their function. Insulin lispro, for example, is a modified form of naturally occurring insulin that removes sugar from the blood more rapidly than the original protein, making it a useful diabetes drug.
David Baker, director of the Institute for Protein Design at the University of Washington, isn’t interested in tinkering, however. Rather than modifying the proteins t...
Source: TIME: Health - May 2, 2024 Category: Consumer Health News Authors: Will Henshall Tags: Uncategorized Accolades franchise Magazine Special Project sponsorshipblock time100health2024 Source Type: news
Does Taking Fish Oil in Pregnancy Raise Child Obesity Risk? Does Taking Fish Oil in Pregnancy Raise Child Obesity Risk?
Study finds slightly higher risk in children at 10 years, but experts say this shouldn ' t change current supplementation recommendations.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Popular 90p item found in your kitchen cupboard that could help blast fat
The tasty ingredient has also been linked to a reduced risk for diabetes, high cholesterol and even cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - May 2, 2024 Category: Consumer Health News Source Type: news
Novo Nordisk Confident as Ozempic, Wegovy Demand Continues
The Danish pharmaceutical giant raised its full-year guidance to reflect better pricing in the U.S. and as global demand for its weight-loss and diabetes drugs continued to outstrip supply.#danish (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2024 Category: Consumer Health News Source Type: news
Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up
Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while competition from rival Eli Lilly...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
FDA Allows Implantable CGM to Integrate With Insulin Pumps FDA Allows Implantable CGM to Integrate With Insulin Pumps
The US Food and Drug Administration grants new status to Sensionics ' EversenseMedscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 1, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
It ’ s Time to Treat Sugar Like Cigarettes
The food we eat impacts every aspect of our lives and our bodies: our hormones, brain chemistry, immune system, microbiome; the list goes on. As consumers, we deserve the right to easily understand our foods’ nutritional value in order to make informed decisions about what we consume and how that will impact our health and well being. This is especially important when it comes to ingredients that are detrimental when eaten in excess, such as sugar. As researchers in functional medicine, longevity, AI, and nutrition, as well as inventors of health-enhancing and life-saving solutions, we have dedicated our professional...
Source: TIME: Health - May 1, 2024 Category: Consumer Health News Authors: Mark Hyman and Ron Gutman Tags: Uncategorized freelance Source Type: news
